4//SEC Filing
WEAVER GREGORY L 4
Accession 0001104659-25-096679
CIK 0001326190other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:24 PM ET
Size
8.5 KB
Accession
0001104659-25-096679
Insider Transaction Report
Form 4
WEAVER GREGORY L
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2025-10-01+57,900→ 57,900 total→ Common Stock, par value $0.0001 (57,900 underlying) - Award
Stock Options (option to buy)
2025-10-01+166,800→ 166,800 totalExercise: $3.87Exp: 2035-10-01→ Common Stock, par value $0.0001 (166,800 underlying)
Footnotes (3)
- [F1]The shares underlying the option become vested and exercisable over four (4) years with 25% of the shares vesting on October 1, 2026, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, subject to the reporting person's continued service on each applicable vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested
- [F3]The RSUs become vested over four (4) years with 25% of the shares vesting October 1, 2026, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001251779
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:24 PM ET
- Size
- 8.5 KB